BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Uterine cancer AND CDKN2A, CDK4I, 1029, ENSG00000147889, P42771, p14, CMM2, ARF, TP16, p16, MTS1, p19, p16INK4a, INK4a, CDKN2, p16INK4, p14ARF, MLM, INK4 AND Treatment
216 results:

  • 1. Should we use risk selection tests for HPV 16 and/or 18 positive cases: Comparison of p16/Ki67 and cytology.
    Mazurec K; Trzeszcz M; Mazurec M; Streb J; Halon A; Jach R
    J Med Virol; 2024 Mar; 96(3):e29500. PubMed ID: 38440951
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Predictive and prognostic biomarkers in female genital tract tumours: an update highlighting their clinical relevance and practical issues.
    Wong RW; Cheung ANY
    Pathology; 2024 Mar; 56(2):214-227. PubMed ID: 38212229
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Impact of the Identification of Nonhuman Genetic Signatures in the Diagnosis and Management of Carcinoma of Unknown Primary.
    Barquín García A; Palacios-Zambrano S; Lozano Alarcón F; Paumard-Hernández B; Quiralte Pulido M; Navarro P; Rodríguez L; Salas Villar I; García-Donas J
    J Natl Compr Canc Netw; 2023 Dec; 22(1D):e237079. PubMed ID: 38150820
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. The use of colposcopy for triage in HPV-positive women aged 65 years and older.
    Kuenkel E; Jaeger A; Bohlmann I; Bergauer F; Kuehler-Obbarius C; Prieske K; Maass-Poppenhusen K; Schmalfeldt B; Woelber L
    Arch Gynecol Obstet; 2024 Apr; 309(4):1561-1567. PubMed ID: 38081959
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. The effects of the LaSota strain of oncolytic Newcastle disease virus vaccine on cervical intraepithelial neoplasia Patients-Clinical cohort study.
    Sharifi N; Bouzari M; Keyvani H; Mehdi Ranjbar M
    Int Immunopharmacol; 2024 Jan; 126():111296. PubMed ID: 38041958
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Whole genome sequencing in high-grade cervical intraepithelial neoplasia patients from different ethnic groups in China.
    Wang J; Li M; Zhao L; Zhou B; Chen H; Duan F; Wang G
    Medicine (Baltimore); 2023 Nov; 102(45):e35953. PubMed ID: 37960754
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Low-Density Lipoprotein Contributes to Endometrial Carcinoma Cell Proliferation, Migration, and Invasion by Activating the JAK-STAT Signaling Pathway.
    Shen L; Zhang C; Cui K; Liang X; Zhu G
    Anal Cell Pathol (Amst); 2023; 2023():4015167. PubMed ID: 37900720
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Cutaneous metastasis from cervical cancer to the scalp and trunk: a case report and review of the literature.
    Dai Y; Zhang Y; Ke X; Liu Y; Zang C
    J Med Case Rep; 2023 Oct; 17(1):435. PubMed ID: 37853494
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Deep molecular tracking over the 12-yr development of endometrial cancer from hyperplasia in a single patient.
    Reid K; Camacho-Vanegas O; Pandya D; Camacho SC; Qiao RF; Kalir T; Padron-Rhenals MM; Beddoe AM; Dottino P; Martignetti JA
    Cold Spring Harb Mol Case Stud; 2023 Dec; 9(4):. PubMed ID: 37848227
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. An EMT-related genes signature as a prognostic biomarker for patients with endometrial cancer.
    Yu Y; Zhang Y; Li Z; Dong Y; Huang H; Yang B; Zhao E; Chen Y; Yang L; Lu J; Qiu F
    BMC Cancer; 2023 Sep; 23(1):879. PubMed ID: 37723477
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Establishment of a high-fidelity patient-derived xenograft model for cervical cancer enables the evaluation of patient's response to conventional and novel therapies.
    Liu L; Wu M; Huang A; Gao C; Yang Y; Liu H; Jiang H; Yu L; Huang Y; Wang H
    J Transl Med; 2023 Sep; 21(1):611. PubMed ID: 37689699
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. The relationship of immunohistochemical SOX-2 staining with histopathological diagnosis in patients with abnormal colposcopic findings.
    Atıgan A; Kılıç D; Karakaya YA; Gök S; Güler ÖT
    Histochem Cell Biol; 2023 Dec; 160(6):555-561. PubMed ID: 37558931
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. The usefulness of p16 and COX-2 expression on the prediction of progression to endometrial cancer.
    Kalkan HE; Akman L; Serin G; Terek MC; Zekioglu O; Ozsaran AA
    Histol Histopathol; 2024 May; 39(5):565-571. PubMed ID: 37503793
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Feasibility of 5-fluorouracil and imiquimod for the topical treatment of cervical intraepithelial neoplasias (CIN) 2/3.
    Desravines N; Hsu CH; Mohnot S; Sahasrabuddhe V; House M; Sauter E; O'Connor S; Bauman JE; Chow HS; Rahangdale L
    Int J Gynaecol Obstet; 2023 Dec; 163(3):862-867. PubMed ID: 37431689
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Unilateral ovarian recurrence 5 years after hysterectomy for microinvasive squamous cervical cancer stage IA1: a rare case report.
    Tong L; Wu L
    BMC Womens Health; 2023 Jul; 23(1):350. PubMed ID: 37393247
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Clinical, pathological, and comprehensive molecular analysis of the uterine clear cell carcinoma: a retrospective national study from TMRG and GINECO network.
    Nigon E; Lefeuvre-Plesse C; Martinez A; Chauleur C; Lortholary A; Favier L; Bats AS; Guille A; AdélaÏde J; Finetti P; de Casteljac V; Provansal M; Mamessier E; Bertucci F; Ray-Coquard I; Sabatier R
    J Transl Med; 2023 Jun; 21(1):408. PubMed ID: 37353806
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Association of MicroRNA-10b Expression and p16 with Pathological Features in Various Stages of Cervical Precancerous Lesions.
    Deng Y; Jiang H; Wu D
    Cell Mol Biol (Noisy-le-grand); 2023 Jan; 69(1):109-113. PubMed ID: 37213147
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. uterine choriocarcinoma coexistence with endometroid adenocacinoma: a case report and literature review.
    Bai L; Chen Y; Han L; Zheng A; Mo X
    BMC Womens Health; 2023 May; 23(1):252. PubMed ID: 37165420
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. High-grade squamous intraepithelial lesion cervicovaginal paps with negative high-risk HPV testing, a prospective study with histological follow-up.
    Agoff SN; Brockmeyer AD; Barrie AM; Larson J
    Diagn Cytopathol; 2023 Aug; 51(8):475-479. PubMed ID: 37086174
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Patient, disease, and survival outcomes for stage IB to stage IV cervical cancer-A population study.
    Wang C; Lester B; Huang L; Sun S; Ko JJ
    Womens Health (Lond); 2023; 19():17455057231164551. PubMed ID: 37052298
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 11.